Ascrinvacumab (Anti-ACVRL1 / ALK-1)

Synonyms: PF-03446962

Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.

Ascrinvacumab (Anti-ACVRL1 / ALK-1)

Purity & Quality Control

Batch: A259401 Purity: 99% Protein concentration: 9.31mg/ml Endotoxin Level: <1EU/mg
99

Choose Selective ALK Inhibitors

Biological Activity

Description Ascrinvacumab (Anti-ACVRL1 / ALK-1) is a human IgG2 monoclonal antibody targeting ALK-1. It can be used for the treatment of hepatocellular carcinoma (HCC), in patients with advanced solid tumors. It also demonstrates its use in antiangiogenic therapy. MW : 150 KD.

Product Details

CAS No. 1463459-96-2
Molecular Weight 150 kDa
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ascrinvacumab (Anti-ACVRL1 / ALK-1) | Ascrinvacumab (Anti-ACVRL1 / ALK-1) supplier | purchase Ascrinvacumab (Anti-ACVRL1 / ALK-1) | Ascrinvacumab (Anti-ACVRL1 / ALK-1) cost | Ascrinvacumab (Anti-ACVRL1 / ALK-1) manufacturer | order Ascrinvacumab (Anti-ACVRL1 / ALK-1) | Ascrinvacumab (Anti-ACVRL1 / ALK-1) distributor